Increases in ATX-LPA-LPA1 signaling are linked to multiple fibrotic diseases, including idiopathic pulmonary fibrosis [11], chronic liver diseases [10], renal interstitial fibrosis [88], and scleroderma [89]. This evidence concerns the gene ENPP2 and idiopathic pulmonary fibrosis.